Literature DB >> 18020894

[Post-myocardial infarction depression].

E García Vicente1, V Del Villar Sordo, E L García Y García.   

Abstract

Major depression is a common finding among patients recovering from a myocardial infarction. Additionally, clinically significant depressive symptoms are present in other patients whose symptom severity or duration does not meet established criteria for a diagnosis of major depression. Over the last decade, increasing evidence suggests that in addition to its effect on patient s quality of life, post-MI depression also deserves attention because of a reported relation to increased morbidity and mortality. This evidence report reviews the studies that have studied depression or depressive symptoms in patients after an MI and focuses on the prevalence, clinical significance, treatment, and methods of evaluating this condition. A large number of studies have evaluated various aspects of post-MI depression including prevalence, its association with mortality, and major adverse events, and treatment.

Entities:  

Mesh:

Year:  2007        PMID: 18020894     DOI: 10.4321/s0212-71992007000700010

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  3 in total

1.  Disturbance of serotonergic neurotransmission in patients with postmyocardial infarction and depression.

Authors:  Gabriel Manjarrez-Gutiérrez; Rodolfo Ramírez-Campillo; Gabriela Borrayo-Sánchez; Jorge Hernández-Rodríguez
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

2.  The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine.

Authors:  Muh Akbar Bahar; Jasper Kamp; Sander D Borgsteede; Eelko Hak; Bob Wilffert
Journal:  Br J Clin Pharmacol       Date:  2018-09-24       Impact factor: 4.335

3.  Effectiveness of a Psychoeducational Group Intervention Carried Out by Nurses for Patients with Depression and Physical Comorbidity in Primary Care: Randomized Clinical Trial.

Authors:  Antonia Raya-Tena; María Isabel Fernández-San-Martin; Jaume Martin-Royo; Rocío Casañas; Glòria Sauch-Valmaña; Cèlia Cols-Sagarra; Elena Navas-Mendez; Roser Masa-Font; Marc Casajuana-Closas; Quintí Foguet-Boreu; Eva María Fernández-Linares; Jacobo Mendioroz-Peña; Susana González-Tejón; Luis Miguel Martín-López; María Francisca Jiménez-Herrera
Journal:  Int J Environ Res Public Health       Date:  2021-03-13       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.